Navigation Links
AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets
Date:4/15/2009

TUSTIN, Calif., April 15 /PRNewswire-FirstCall/ -- AMDL, Inc., (NYSE Alternext US: ADL), an international pharmaceutical company with operations in China and the US, today announced financial results for the fourth quarter and year ended December 31, 2008.

For the 12 months ended December 31, 2008, the Company demonstrated strong top-line growth and sales performance. Gross revenues increased over 124%, reaching just over $33.6 million compared to approximately $15 million for the same period in FY2007. The significant growth in revenues was due to an increase in sales of existing products in the growing China healthcare market, which included AMDL's best-selling human placenta extract (HPE)-based skin care product, Domperidone anti-emetic drug, and other high-quality ethical pharmaceutical products.

Gross profits for FY2008 increased to approximately $14.8 million compared to approximately $8.1 million for the same period in FY2007, with a gross profit margin of 52% of net sales as compared to a gross profit of 54% for the same period in FY2007. Gross profits increased approximately US$6.7 million from FY2007 to FY2008, primarily due to continued product sales growth in China. As a percentage of net revenues, gross profits declined slightly due to a change in AMDL's product mix, which shifted away from certain products reliant on a non-operating small injectable manufacturing line, to other slightly less profitable products. The Company also had an increase in the cost of raw materials and manufacturing overhead. The non-operating small injectable production line is back in trial production and AMDL expects to resume full production beginning in the second quarter FY2009. Operating income for the year ended December 31, 2008 totaled approximately US$3.3 million compared to a loss of approximately $1.79 million reported for the same period in 2007, an increase of
'/>"/>

SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc.
2. AMDL, Inc. Issues Correction to January 30, 2009 Press Release Announcing Closing of Private Placement of Senior Notes
3. AMDL, Inc. Announces Final Closing of Private Placement of Senior Notes
4. AMDL, Inc. Chairman & CEO Announces Expert Opinion on Chinas Economic Forecast
5. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
6. Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
7. AMDL, Inc. Selected as #1 Small-Cap Stock Pick for 2009
8. Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors
9. Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
10. Study reports success in treating a rare retinal disorder
11. Johnson & Johnson Reports 2009 First-Quarter Results:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the socks were first ... and athletic trainers. Their significant popularity has inspired four new, fun shades including: ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ActiveBunch.com recently ... passion for social fitness. Built to function as a lifestyle community, Active Bunch allows ... the opportunity to network, meet, and participate in discussions or group events. , ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... company , announced today that it has reached an agreement to acquire ... CleanItSupply.com the largest distributor of Rubbermaid Commercial Products on the web today. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Octo Consulting Group, (Octo), a ... government, has announced they are among nine contractors awarded the U.S. Securities and ... contract not to exceed $250 million. , To achieve the goals of ...
(Date:7/2/2015)... OR (PRWEB) , ... July 02, 2015 , ... Hand ... During the current summer flu season, according to fresh water advocate and radio host ... on the hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied ...
Breaking Medicine News(10 mins):Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3
... Inc. (CTI) (Nasdaq and MTA: CTIC) today announced that Richard Van der Jagt, M.D. of ... the 2009 Pan Pacific Lymphoma Conference on Monday, June 22, 2009. The conference will be ... Hawaii. , , , ... 2009 Pan Pacific Lymphoma Conference, ...
... , , , President Obama Calls For Health ... 15 The American Medical Association warmly welcomed U.S. ... Like the president, the AMA is committed to health reform this ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) , ...
... MBA, FACPE, Ameritox,s Senior Vice President and Chief Medical Officer, ... for the American College of Physician Executives (ACPE), a national ... , Dr. Leider became an ACPE member 20 years ... College for 13 years teaching courses on improving the quality ...
... 16, 2009 at 9:00 a.m. Eastern Time , , ... ALXA ) announced today that it has exercised ... Allegro. The purchase of Symphony Allegro, which is subject ... 2009. , , Alexza and Symphony Capital Partners, LP ...
... June 15 Citing evidence that even a very low level ... the Council of State and Territorial Epidemiologists (CSTE) is recommending a ... adults. In a vote at the CSTE annual conference in Buffalo, ... 10 ug/dl or more in adults as "elevated" -- the same ...
... 15, 2009 (BRONX, NY) In a study ... researchers from Albert Einstein College of Medicine of Yeshiva ... HIV-positive individuals are most likely to develop deadly fungal ... of meningitis affects more than 900,000 HIV-infected people globallymost ...
Cached Medicine News:Health News:President Obama Receives Warm Welcome from AMA Physicians 2Health News:Ameritox(R) CMO Elected Chairman of the American College of Physician Executives Board 2Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 2Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 3Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 4Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 5Health News:Alexza Announces Agreement to Acquire Symphony Allegro, Including All Rights to AZ-004, AZ-104 and AZ-002 6Health News:CSTE Leads Effort to Improve Blood Lead Reporting 2Health News:CSTE Leads Effort to Improve Blood Lead Reporting 3Health News:Predicting fatal fungal infections 2
(Date:7/2/2015)... , July 2, 2015   BioLife Solutions , Inc. ... of proprietary clinical grade cell and tissue hypothermic storage ... cloud hosted biologistics cold chain management app for ... that Seattle Business Magazine has included BioLife in ... for in Washington state for 2015. ...
(Date:7/2/2015)... -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced ... in the Southern District of West Virginia ... Ethicon for a single trial to take place on ... women include claims from the women plaintiffs that they ... Johnson,s Ethicon subsidiary. The cases against Ethicon are among ...
(Date:7/1/2015)... Ill. , July 1, 2015 ... nationwide group of state and regional professional rheumatology ... survey of rheumatologists that explored perceptions of biosimilars ... on patients. Biosimilars are medicines ... biologic medicines. They are notably different from generic ...
Breaking Medicine Technology:BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2
... Anpath Group, Inc.,(OTC Bulletin Board: ANPG), reported ... (ESI) announced that the U.S. Environmental,Protection Agency ... claims to,its disinfectant/sanitizer, EnviroTru(R) for use of ... MRSA (scientifically known as Methicillin,Resistant Staphylococcus aureus) ...
... (NYSE:,AZN) today announced that it submitted a supplemental ... Drug Administration (FDA) for approval of a new,indication ... long-term maintenance treatment of asthma in,pediatric patients ages ... approved,for the long-term maintenance treatment of asthma in ...
Cached Medicine Technology:Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant 2Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant 3Anpath Group, Inc. Announces Addition of MRSA and VRE Claims for Its EnviroTru(R) Disinfectant 4AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 2AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 3AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 4AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 5AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six 6
The Surgiflex WAVE is a comfortable, easy to use, versatile, and interchangeable suction-irrigation device....
... Clinicians are demanding smaller, higher performing ... clinical and operational challenges. The new ... powerful architecture for superb High Definition ... and ease-of-use; and a versatile suite ...
The Cardiff Acuity Test is designed specifically for,acuity measurement in children aged 1 to 3 years. The,test is also helpful with other age groups with,intellectual impairment, dementia, hea...
... InfinixTM CF-i/SP brings revolutionary flexibility to ... enables operators to move the C-arm ... to obtain the optimal angle for ... features an 8-inch cardiac flat panel ...
Medicine Products: